Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
The extracellular matrix (ECM) is the complex network of proteins that surrounds cells in multicellular organisms. Due to its diverse nature and composition, the ECM has a multifaceted role in both normal tissue homeostasis and pathophysiology. It provides structural support, segregates tissues from...
Main Authors: | Roy, David M, Walsh, Logan A |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090043/ |
Similar Items
-
Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy
by: Srikanth, Sandhya, et al.
Published: (2016) -
Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
by: Musante, Luca, et al.
Published: (2015) -
Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
by: Lösch, A., et al.
Published: (1996) -
LPS Counter Regulates RNA Expression of Extracellular Proteases and Their Inhibitors in Murine Macrophages
by: Hald, Andreas, et al.
Published: (2012) -
Inhibitors of Serine Proteases in Regulating the Production and Function of Neutrophil Extracellular Traps
by: Majewski, Pawel, et al.
Published: (2016)